These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21364952)

  • 1. Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach.
    Edwards YJ; Beecham GW; Scott WK; Khuri S; Bademci G; Tekin D; Martin ER; Jiang Z; Mash DC; ffrench-Mullen J; Pericak-Vance MA; Tsinoremas N; Vance JM
    PLoS One; 2011 Feb; 6(2):e16917. PubMed ID: 21364952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.
    Liu X; Cheng R; Verbitsky M; Kisselev S; Browne A; Mejia-Sanatana H; Louis ED; Cote LJ; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Marder K; Clark LN; Lee JH
    BMC Med Genet; 2011 Aug; 12():104. PubMed ID: 21812969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathway analysis of genome-wide association studies for Parkinson's disease.
    Song GG; Lee YH
    Mol Biol Rep; 2013 Mar; 40(3):2599-607. PubMed ID: 23238920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease.
    Martins M; Rosa A; Guedes LC; Fonseca BV; Gotovac K; Violante S; Mestre T; Coelho M; Rosa MM; Martin ER; Vance JM; Outeiro TF; Wang L; Borovecki F; Ferreira JJ; Oliveira SA
    PLoS One; 2011; 6(10):e25443. PubMed ID: 22003392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-mapping of Parkinson's disease susceptibility loci identifies putative causal variants.
    Schilder BM; Raj T
    Hum Mol Genet; 2022 Mar; 31(6):888-900. PubMed ID: 34617105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease.
    Dumitriu A; Golji J; Labadorf AT; Gao B; Beach TG; Myers RH; Longo KA; Latourelle JC
    BMC Med Genomics; 2016 Jan; 9():5. PubMed ID: 26793951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
    Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
    Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide meta-analysis of genetic susceptible genes for Type 2 Diabetes.
    Hale PJ; López-Yunez AM; Chen JY
    BMC Syst Biol; 2012; 6 Suppl 3(Suppl 3):S16. PubMed ID: 23281828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
    Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
    Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating pathway analysis and genetics of gene expression for genome-wide association studies.
    Zhong H; Yang X; Kaplan LM; Molony C; Schadt EE
    Am J Hum Genet; 2010 Apr; 86(4):581-91. PubMed ID: 20346437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Berge-Seidl V; Pihlstrøm L; Maple-Grødem J; Forsgren L; Linder J; Larsen JP; Tysnes OB; Toft M
    Neurosci Lett; 2017 Sep; 658():48-52. PubMed ID: 28830825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication of GWAS associations for GAK and MAPT in Parkinson's disease.
    Rhodes SL; Sinsheimer JS; Bordelon Y; Bronstein JM; Ritz B
    Ann Hum Genet; 2011 Mar; 75(2):195-200. PubMed ID: 21058943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic convergence of locus-based GWAS meta-analysis identifies AXIN1 as a novel Parkinson's gene.
    Saeed M
    Immunogenetics; 2018 Sep; 70(9):563-570. PubMed ID: 29923028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous Network Edge Prediction: A Data Integration Approach to Prioritize Disease-Associated Genes.
    Himmelstein DS; Baranzini SE
    PLoS Comput Biol; 2015 Jul; 11(7):e1004259. PubMed ID: 26158728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide association data classification and SNPs selection using two-stage quality-based Random Forests.
    Nguyen TT; Huang J; Wu Q; Nguyen T; Li M
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S5. PubMed ID: 25708662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease.
    Holmans P; Moskvina V; Jones L; Sharma M; ; Vedernikov A; Buchel F; Saad M; Bras JM; Bettella F; Nicolaou N; Simón-Sánchez J; Mittag F; Gibbs JR; Schulte C; Durr A; Guerreiro R; Hernandez D; Brice A; Stefánsson H; Majamaa K; Gasser T; Heutink P; Wood NW; Martinez M; Singleton AB; Nalls MA; Hardy J; Morris HR; Williams NM
    Hum Mol Genet; 2013 Mar; 22(5):1039-49. PubMed ID: 23223016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying SNP targeted pathways in partial epilepsies with genome-wide association study data.
    Bakir-Gungor B; Baykan B; Ugur İseri S; Tuncer FN; Sezerman OU
    Epilepsy Res; 2013 Jul; 105(1-2):92-102. PubMed ID: 23498093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.